In the News

Bots Boost Liver Cancer Outcome

Liver cancer, primarily hepatocellular carcinoma (HCC), is the third most common contributor to cancer-related deaths worldwide. Early-stage HCC has a better prognosis than advanced-stage HCC and can be treated with minimally invasive surgery, including robotic-assisted and laparoscopic options. However, few studies have examined the presumably unique and discrepant short-term and long-term outcomes of robotic-assisted and laparoscopic surgeries. Read more.

Blood test figures in cancer risk for people with HIV

In the clinical care of people living with HIV, various types of blood cells are routinely counted to assess the immune system, among them CD4+ cells, or T helper cells, and CD8+ cells, or cytotoxic T cells. These types of white blood cells work together to clear infections and prevent and kill cancer cells. While a normal CD4/CD8 ratio is about 2:1, it’s typically lower in people with HIV. Read more.

Study shows how a protein coding gene confers breast cancer susceptibility during DNA transcription

New research from Vanderbilt-Ingram Cancer Center provides insight into how genetic variants convey breast cancer susceptibility by altering the transcription factor proteins that convert DNA strands into RNA.

Spirituality may help reduce end-stage kidney disease risk

Researchers from Vanderbilt’s Division of Nephrology and Hypertension have identified an under-studied characteristic that may have a protective effect on end-stage kidney disease (ESKD) risk among vulnerable populations. The study, led by Devika Nair, MD, MSCI, assistant professor of Medicine within the Division of Nephrology and Hypertension, found that adults who self-identified as Black and reported high levels of spirituality had a statistically significant reduced risk for developing ESKD — independent of demographics, other psychosocial factors and lifestyle behaviors.

Geographic Variation in Women’s Colorectal Cancer Survival

A first look into where early onset mortality spikes among U.S. women. Women with early onset colorectal cancer have a greater risk of dying from the disease depending upon their county of residence, according to a study published in Clinical and Translational Gastroenterology.